CBT Stock Forecast 2025-2026
Distance to CBT Price Targets
CBT Price Momentum
10 Quality Stocks Worth Considering Now
Researching Cabot (CBT) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on CBT and similar high-potential opportunities.
Latest CBT Stock Price Targets & Analyst Predictions
Based on our analysis of 9 Wall Street analysts, CBT has a neutral consensus with a median price target of $95.00 (ranging from $83.00 to $97.00). The overall analyst rating is Buy (7.2/10). Currently trading at $78.33, the median forecast implies a 21.3% upside. This outlook is supported by 2 Buy, 2 Hold, and 1 Sell ratings.
Conversely, the most conservative target is provided by Joshua Spector at UBS, suggesting a 6.0% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CBT Analyst Ratings
CBT Price Target Range
Latest CBT Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CBT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 7, 2025 | UBS | Joshua Spector | Neutral | Maintains | $83.00 |
| Feb 21, 2025 | JP Morgan | Jeffrey Zekauskas | Underweight | Maintains | $85.00 |
| Jan 7, 2025 | Mizuho | John Roberts | Outperform | Maintains | $110.00 |
| Nov 11, 2024 | JP Morgan | Jeffrey Zekauskas | Underweight | Downgrade | $105.00 |
| Nov 5, 2024 | Mizuho | John Roberts | Outperform | Maintains | $122.00 |
| Aug 7, 2024 | JP Morgan | Jeffrey Zekauskas | Neutral | Maintains | $105.00 |
| Aug 6, 2024 | UBS | Joshua Spector | Neutral | Maintains | $98.00 |
| May 7, 2024 | Mizuho | John Roberts | Buy | Maintains | $109.00 |
| May 7, 2024 | UBS | Joshua Spector | Neutral | Maintains | $103.00 |
| Apr 18, 2024 | Deutsche Bank | David Begleiter | Hold | Downgrade | $95.00 |
| Mar 27, 2024 | Mizuho | John Roberts | Buy | Initiates | $104.00 |
| Jan 8, 2024 | UBS | Joshua Spector | Neutral | Downgrade | $87.00 |
| Dec 14, 2023 | UBS | Joshua Spector | Buy | Maintains | $90.00 |
| Nov 7, 2023 | UBS | Joshua Spector | Buy | Maintains | $83.00 |
| Aug 11, 2023 | JP Morgan | Jeffrey Zekauskas | Neutral | Maintains | $70.00 |
| Aug 8, 2023 | Credit Suisse | John Roberts | Outperform | Maintains | $82.00 |
| Jun 20, 2023 | Loop Capital | Christopher Kapsch | Buy | Maintains | $103.00 |
| Jun 6, 2023 | JP Morgan | Neutral | Downgrade | $0.00 | |
| May 18, 2023 | Deutsche Bank | David Begleiter | Buy | Maintains | $80.00 |
| May 9, 2023 | Credit Suisse | John Roberts | Outperform | Maintains | $91.00 |
Cabot Corporation (CBT) Competitors
The following stocks are similar to Cabot based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Cabot Corporation (CBT) Financial Data
Cabot Corporation has a market capitalization of $4.25B with a P/E ratio of 10.4x. The company generates $3.99B in trailing twelve-month revenue with a 10.6% profit margin.
Revenue growth is -0.3% quarter-over-quarter, while maintaining an operating margin of +16.2% and return on equity of +31.2%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Cabot Corporation (CBT) Business Model
About Cabot Corporation
Specialty chemicals and performance materials provider.
The company generates revenue through the production and supply of essential materials like carbon black, fumed silica, and activated carbon. These materials are utilized in various applications, including tires, coatings, adhesives, and batteries, serving key industries such as automotive, construction, and electronics.
Founded in 1882, Cabot Corporation emphasizes innovation and sustainability, striving to minimize the environmental impact of its products and operations. Its global presence and expertise in material science highlight its importance in advancing technologies and supporting infrastructure development.
Company Information
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
4,151
CEO
Mr. Sean D. Keohane
Country
United States
IPO Year
1980
Website
www.cabotcorp.comCabot Corporation (CBT) Latest News & Analysis
Cabot Corporation (NYSE: CBT) will release Q2 fiscal 2025 results on May 5, 2025, after market close, followed by a conference call on May 6, 2025, at 8:00 am ET.
Cabot Corporation's upcoming earnings release and conference call could impact stock prices and investor sentiment, providing insights into its financial health and growth prospects.
Cabot (CBT) reported earnings 30 days ago; investors should monitor upcoming developments and market reactions for potential impacts on the stock.
Earnings reports can impact stock prices significantly. Upcoming expectations or guidance from Cabot may influence investor sentiment and trading strategies.
Cabot Corporation (CBT) shows strong growth and income potential with improving EBIT margins and revenue in its two segments. It has rising EPS, robust cash flow, and an active share buyback program.
Cabot Corporation's strong performance, growth in EBIT margins, and robust cash flow signal potential for higher shareholder returns, making it an attractive investment opportunity.
Cabot Corporation (NYSE: CBT) will hold its Q1 2025 earnings conference call on January 30, 2025, at 8:00 AM ET, featuring key executives and analysts from major firms.
The earnings call provides insight into Cabot Corporation's financial performance and strategic direction, influencing stock valuations and investor sentiment.
Cabot's Q1 results fell short of earnings and revenue estimates but showed improvement in EBIT and adjusted EPS metrics.
Cabot's missed earnings and revenue estimates could signal operational challenges, but stronger EBIT and adjusted EPS suggest improved efficiency, impacting future growth and valuation.
Cabot Corp Reports First Quarter Fiscal 2025 Results
2 months agoCabot Corporation (NYSE: CBT) reported Q1 FY2025 results: Diluted EPS at $1.67, Adjusted EPS at $1.76 (+13% YoY). EBIT rose in Performance Chemicals (+32%). Cash flows supported $66M in shareholder returns.
Cabot Corporation's strong Q1 results, with a 13% increase in Adjusted EPS and solid cash flows, indicate robust financial health and effective growth strategies, positively influencing investor confidence.
Frequently Asked Questions About CBT Stock
What is Cabot Corporation's (CBT) stock forecast for 2025?
Based on our analysis of 9 Wall Street analysts, Cabot Corporation (CBT) has a median price target of $95.00. The highest price target is $97.00 and the lowest is $83.00.
Is CBT stock a good investment in 2025?
According to current analyst ratings, CBT has 2 Buy ratings, 2 Hold ratings, and 1 Sell ratings. The stock is currently trading at $78.33. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CBT stock?
Wall Street analysts predict CBT stock could reach $95.00 in the next 12 months. This represents a 21.3% increase from the current price of $78.33. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Cabot Corporation's business model?
The company generates revenue through the production and supply of essential materials like carbon black, fumed silica, and activated carbon. These materials are utilized in various applications, including tires, coatings, adhesives, and batteries, serving key industries such as automotive, construction, and electronics.
What is the highest forecasted price for CBT Cabot Corporation?
The highest price target for CBT is $97.00 from at , which represents a 23.8% increase from the current price of $78.33.
What is the lowest forecasted price for CBT Cabot Corporation?
The lowest price target for CBT is $83.00 from Joshua Spector at UBS, which represents a 6.0% increase from the current price of $78.33.
What is the overall CBT consensus from analysts for Cabot Corporation?
The overall analyst consensus for CBT is neutral. Out of 9 Wall Street analysts, 2 rate it as Buy, 2 as Hold, and 1 as Sell, with a median price target of $95.00.
How accurate are CBT stock price projections?
Stock price projections, including those for Cabot Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.